Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03577691 · ClinicalTrials.gov registry record · NA
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03577691 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants.
The verdict
NCT03577691, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The trial is a prospective, randomized study to determine the efficacy of training for use of a web based Decision Aid for Hydroxyurea(HU) usage among subjects with Sickle Cell Disease(SCD). Subjects are randomized primarily either to using a web based decision aid with training versus without training. Subjects in each group will be further randomized to 1) subjects receiving pretest surveys; and 2) subjects that do not receive pretest surveys.
Interventions
- OTHER Training for use of web based Decision Aid
- OTHER No training for use of web based Decision Aid
- OTHER Pretest surveys and posttest surveys
- OTHER Only posttest surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-08-03 |
| Est. Completion | 2019-07-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03577691
The ClinicalTrials.gov registry entry for NCT03577691 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Training for use of web based Decision Aid is the first listed.
NCT03577691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03577691 about?
NCT03577691 is a clinical study titled "Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease". The trial is a prospective, randomized study to determine the efficacy of training for use of a web based Decision Aid for Hydroxyurea(HU) usage among subjects with Sickle Cell Disease(SCD). Subjects are randomized primarily either to using a web based decision aid with training versus without train...
What is the current status of trial NCT03577691?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-08-03. Estimated completion is 2019-07-03.
What interventions are being tested in trial NCT03577691?
The interventions under investigation include: Training for use of web based Decision Aid (OTHER), No training for use of web based Decision Aid (OTHER), Pretest surveys and posttest surveys (OTHER), Only posttest surveys (OTHER).
Who is sponsoring clinical trial NCT03577691?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.